297
Views
1
CrossRef citations to date
0
Altmetric
Review

Targeting ZBP-89 for the treatment of hepatocellular carcinoma

, , , , , & show all
Pages 817-822 | Received 04 Jun 2018, Accepted 23 Aug 2018, Published online: 06 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, Maria R. Emma, Giuseppa Augello, Antonella Cusimano, Antonina Azzolina, Giuseppe Montalto, Melchiorre Cervello & James A. McCubrey. (2019) RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma. Expert Opinion on Therapeutic Targets 23:11, pages 915-929.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.